Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Iris Biotech GmbH logo — Empowering Peptide Innovation

Iris Biotech GmbH

Empowering Peptide Innovation

Founded 2001 Germany Marktredwitz, Germany 19 employees Biotechnology

General Information

Company Name Iris Biotech GmbH
Founded Year 2001
Location Germany Marktredwitz, Germany +2
Employees 19
Industries Biotechnology
Social

Get notified when Iris Biotech GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Iris Biotech GmbH

Iris Biotech GmbH is a German biotechnology company established in 2001, with a focus on enabling peptide innovation. Over the years, the company has expanded its portfolio to encompass a unique range of standard reagents and unconventional building blocks, supported by custom synthesis services. Its commitment lies in providing essential support to its clientele, offering expertise, cutting-edge products, necessary analytics, and documentation to facilitate projects across various scales, from research to commercial production. The company's offerings cater to diverse segments within the biotechnology field. In the realm of drug discovery, Iris Biotech presents an array of critical components such as protected amino acids, coupling reagents, linkers, resins, natural and unusual amino acids, derivatives, fatty acid derivatives, and myriad other building blocks and resins. For drug delivery, the company boasts an extensive portfolio of PEGylation reagents, catering to a broad spectrum of requirements, including short, monodisperse hydrophilic linkers to long, polydisperse derivatives, alongside novel polymers with improved biodegradability. The company's innovative Linkerology section offers PROTAC building blocks, functionalized linkers, and fullerenes, adding distinct value to various research applications, from antioxidants to drug delivery. In its latest foray, Iris Biotech has ventured into the life sciences domain, introducing inhibitors, metabolites, substrates, fluorescent dyes, and natural products with biological and pharmaceutical significance, in addition to offering carbohydrates and Amadori and Maillard reaction products. Presently, there is no available information regarding the company's last investment and associated investors. However, considering its expansive and innovative product portfolio across critical domains in biotechnology, Iris Biotech GmbH presents itself as a compelling entity in the biotechnology sector, with potential for further growth, and potentially piquing the interest of venture capital firms looking to invest in cutting-edge biotech solutions.

Taxonomy: Peptide Synthesis, PEGylation, Drug Discovery, Drug Delivery, Life Science Research, BioCatalysis, Click Chemistry, Enzyme Substrates for Diagnostics, Resins, ADC Linkers, Amino Acids, Linkerology, PROTACs, Fluorescent Dyes, Carbohydrates

No funding data available for Iris Biotech GmbH yet.

Get notified when Iris Biotech GmbH raises funding

Iris Biotech GmbH Alternatives & Competitors

Iris Biotech GmbH vs
Advanced ChemTech
Advanced ChemTech

Supplier of quality chemicals and peptide synthesizers to the research and pharmaceutical market.

1 employees
Manufacturing, Pharmaceutical
Iris Biotech GmbH vs
ChemScene
ChemScene United States

Chemscene specializes in Buliding blocks, Bioactive small molecules, APIs and intermediate productio...

43 employees
Biotechnology, Manufacturing

FAQ About Iris Biotech GmbH

Empowering Peptide Innovation
Iris Biotech GmbH was founded in 2001.
Iris Biotech GmbH is headquartered in Marktredwitz, Germany.
Iris Biotech GmbH operates in the following industries: Biotechnology.
Iris Biotech GmbH has approximately 19 employees.
Top alternatives and competitors to Iris Biotech GmbH include Advanced ChemTech, ChemScene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Iris Biotech GmbH and Advanced ChemTech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Iris Biotech GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy